Confo Therapeutics Press Release
2023-06-15

Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera

• Collaboration to make use…
read more
Minoryx Press Release
2023-06-05

Minoryx gains FDA approval to initiate a Phase 3 clinical trial in patients with cerebral Adrenoleukodystrophy

US trial with leriglitazone to…
read more
Coave Press Release
2023-06-05

Coave Therapeutics announces Positive 12-months Data from Ongoing Phase I/II Clinical Trial of CTx-PDE6b in Patients with Retinitis Pigmentosa Caused by Bi-allelic Mutations in PDE6b

- CTx-PDE6b demonstrated clinically meaningful…
read more
ONA Press Release
2023-06-05

ONA Therapeutics Announces the Appointment of Dr Pamela Klein to its Board of Directors

• Leading medical oncologist and…
read more
Indigo Press Release
2023-05-15

Indigo Appoints Dr. Arun Venkatasubramanian as Chief Technology Officer

Arun is an award-winning engineer…
read more
Minoryx Press Release
2023-04-25

Minoryx presents positive interim results from NEXUS registration study for leriglitazone targeting pediatric ALD patients with cerebral adrenoleukodystrophy (cALD)

Initial evidence of disease stabilization…
read more
Press Release Tubulis
2023-04-20

Tubulis Announces Strategic License Agreement with Bristol Myers Squibb to Develop Next Generation ADCs for the Treatment of Cancer Patients

Companies join forces bringing together…
read more
Confo Therapeutics Press Release
2023-03-30

Confo Therapeutics Enters into Collaboration Agreement with Daiichi Sankyo to Discover Novel Medicines for CNS Diseases

Collaboration to make use of…
read more
Exevir Press Release
2023-03-13

ExeVir Bio and VIB Announce Data on a New Therapy for Prevention and Treatment for COVID-19.

ExeVir Bio and VIB-UGent’s bioRxiv…
read more
Confo Therapeutics Press Release
2023-03-02

Confo Therapeutics Announces Global Licensing Agreement with Lilly for Peripheral Pain Candidate, CFTX-1554

Confo to receive upfront and…
read more